167 related articles for article (PubMed ID: 24607589)
21. In vitro optimization of non-small cell lung cancer activity with troxacitabine, L-1,3-dioxolane-cytidine, prodrugs.
Radi M; Adema AD; Daft JR; Cho JH; Hoebe EK; Alexander LE; Peters GJ; Chu CK
J Med Chem; 2007 May; 50(9):2249-53. PubMed ID: 17419604
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis, and biological evaluation of novel aminobisphosphonates possessing an in vivo antitumor activity through a gammadelta-T lymphocytes-mediated activation mechanism.
Simoni D; Gebbia N; Invidiata FP; Eleopra M; Marchetti P; Rondanin R; Baruchello R; Provera S; Marchioro C; Tolomeo M; Marinelli L; Limongelli V; Novellino E; Kwaasi A; Dunford J; Buccheri S; Caccamo N; Dieli F
J Med Chem; 2008 Nov; 51(21):6800-7. PubMed ID: 18937434
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and biological activity of prodrug inhibitors of the thioredoxin-thioredoxin reductase system.
Wipf P; Lynch SM; Powis G; Birmingham A; Englund EE
Org Biomol Chem; 2005 Nov; 3(21):3880-2. PubMed ID: 16240002
[TBL] [Abstract][Full Text] [Related]
24. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
[TBL] [Abstract][Full Text] [Related]
25. Design, Synthesis, and Biological Evaluation of Potential Prodrugs Related to the Experimental Anticancer Agent Indotecan (LMP400).
Lv PC; Elsayed MS; Agama K; Marchand C; Pommier Y; Cushman M
J Med Chem; 2016 May; 59(10):4890-9. PubMed ID: 27097152
[TBL] [Abstract][Full Text] [Related]
26. Improved synthesis of N-benzylaminoferrocene-based prodrugs and evaluation of their toxicity and antileukemic activity.
Daum S; Chekhun VF; Todor IN; Lukianova NY; Shvets YV; Sellner L; Putzker K; Lewis J; Zenz T; de Graaf IA; Groothuis GM; Casini A; Zozulia O; Hampel F; Mokhir A
J Med Chem; 2015 Feb; 58(4):2015-24. PubMed ID: 25633601
[TBL] [Abstract][Full Text] [Related]
27. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of novel pyrrolo[2,1-c][1,4]benzodiazepine prodrugs for use in antibody-directed enzyme prodrug therapy.
Masterson LA; Spanswick VJ; Hartley JA; Begent RH; Howard PW; Thurston DE
Bioorg Med Chem Lett; 2006 Jan; 16(2):252-6. PubMed ID: 16290933
[TBL] [Abstract][Full Text] [Related]
29. Self-assembling nanowires of an amphiphilic camptothecin prodrug derived from homologous derivative conjugation.
He D; Zhang W; Deng H; Huo S; Wang YF; Gong N; Deng L; Liang XJ; Dong A
Chem Commun (Camb); 2016 Dec; 52(98):14145-14148. PubMed ID: 27869268
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and evaluation of water-soluble etoposide esters of malic acid as prodrugs.
Chen J; Du W
Med Chem; 2013 Aug; 9(5):740-7. PubMed ID: 23061567
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and biological evaluation of (+)-neopeltolide analogues: importance of the oxazole-containing side chain.
Fuwa H; Noguchi T; Kawakami M; Sasaki M
Bioorg Med Chem Lett; 2014 Jun; 24(11):2415-9. PubMed ID: 24792465
[TBL] [Abstract][Full Text] [Related]
32. Novel prodrugs of tegafur that display improved anticancer activity and antiangiogenic properties.
Engel D; Nudelman A; Tarasenko N; Levovich I; Makarovsky I; Sochotnikov S; Tarasenko I; Rephaeli A
J Med Chem; 2008 Jan; 51(2):314-23. PubMed ID: 18163551
[TBL] [Abstract][Full Text] [Related]
33. Two-step activation prodrugs: transplatin mediated binding of chemotherapeutic agents to vitamin B12.
Tran MT; Furger E; Alberto R
Org Biomol Chem; 2013 May; 11(19):3247-54. PubMed ID: 23584074
[TBL] [Abstract][Full Text] [Related]
34. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
35. Tumor cell-specific prodrugs using arsonic acid-presenting iron oxide nanoparticles with high sensitivity.
Minehara H; Narita A; Naka K; Tanaka K; Chujo M; Nagao M; Chujo Y
Bioorg Med Chem; 2012 Aug; 20(15):4675-9. PubMed ID: 22743089
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of new lipophilic ipomeanol analogues and their cytotoxic activities.
Krauss J; Unterreitmeier D
Arch Pharm (Weinheim); 2005 Jan; 338(1):44-8. PubMed ID: 15674804
[TBL] [Abstract][Full Text] [Related]
37. Bisphosphonate prodrugs.
Vepsäläinen JJ
Curr Med Chem; 2002 Jun; 9(12):1201-8. PubMed ID: 12052172
[TBL] [Abstract][Full Text] [Related]
38. New Taxol (paclitaxel) prodrugs designed for ADEPT and PMT strategies in cancer chemotherapy.
Alaoui AE; Saha N; Schmidt F; Monneret C; Florent JC
Bioorg Med Chem; 2006 Jul; 14(14):5012-9. PubMed ID: 16554162
[TBL] [Abstract][Full Text] [Related]
39. Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis.
Houghton TJ; Tanaka KS; Kang T; Dietrich E; Lafontaine Y; Delorme D; Ferreira SS; Viens F; Arhin FF; Sarmiento I; Lehoux D; Fadhil I; Laquerre K; Liu J; Ostiguy V; Poirier H; Moeck G; Parr TR; Far AR
J Med Chem; 2008 Nov; 51(21):6955-69. PubMed ID: 18834106
[TBL] [Abstract][Full Text] [Related]
40. Preparation of a camptothecin prodrug with glutathione-responsive disulfide linker for anticancer drug delivery.
Xu Z; Wang D; Xu S; Liu X; Zhang X; Zhang H
Chem Asian J; 2014 Jan; 9(1):199-205. PubMed ID: 24136878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
